Overview

Huntington's disease is a progressive neurodegenerative condition that primarily affects movement, cognition and behavior. It is caused by a hereditary mutation and leads to gradual loss of neurons in specific brain regions. Symptoms usually begin in mid-adulthood but can appear earlier or later. The illness worsens over time and, in many cases, shortens life expectancy by about a decade to two decades after symptom onset.

Causes and genetics

The disorder results from a mutation in a single gene, which follows an autosomal dominant inheritance pattern: a person who carries the mutation has approximately a 50% chance of transmitting it to each child. This genetic basis means family history is a key factor. Genetic testing can identify the mutation in individuals at risk and is often discussed in genetic counseling. For scientific details see information about the causative gene and research summaries at specialist resources.

Typical signs and progression

Clinical features combine motor, cognitive and psychiatric elements. Early or prominent motor findings often include involuntary, dance-like movements known as chorea. Alongside movement problems there is progressive decline in thinking skills and memory, which may be described in clinical literature as executive dysfunction and short-term memory impairment (memory loss). Behavioral changes can include mood disturbances, irritability and changes in social behavior.

Symptoms and affected systems

  • Motor: involuntary jerks, poor coordination, difficulty walking and swallowing (movement problems).
  • Cognitive: reduced planning, problem-solving, and memory difficulties.
  • Psychiatric: depression, anxiety, apathy and personality changes.

Course, frequency and notable facts

The course is typically progressive and irreversible. Average survival after symptom onset is often cited as around fifteen years, though this varies with age at onset and medical care. Estimates of prevalence vary by population; in some regions the condition affects roughly 4–10 per 100,000 people overall. The disease targets specific brain structures related to movement and cognition; detailed descriptions of these affected regions can be found in specialized neurology sources (brain region overview).

Management and implications

There is currently no cure. Treatment focuses on symptom management: medications can reduce involuntary movements and treat psychiatric symptoms, while multidisciplinary care—physical therapy, speech therapy, nutritional support and psychological services—helps maintain function and quality of life. Genetic counseling and predictive testing are important for family planning and early decision-making. For patient resources and clinical guidelines, consult reputable health organizations and support groups (patient guidance).

Huntington's disease remains an active area of research, with ongoing studies exploring disease-modifying therapies and improved supportive care models to slow progression and address the wide-ranging needs of affected individuals and families.